Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local antimicrobial administration for intra-abdominal abscesses
2018-001376-38Phase 4Active
- Sponsor
- MarÃa Dolores Sousa Regueiro
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meropenem in intra-abdominal abscess (IAA) (2 arms), sponsored by MarÃa Dolores Sousa Regueiro. Primary endpoint: Clinical response. Started Jul 2019; status: active.
02
Drugs
meropenem
03
Conditions
intra-abdominal abscess (IAA)
Beyond the preview
Go deeper on 2018-001376-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001376-38.